Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 281-289

  Peng, Shian Yang ^b   Chou, Sheng Ping ^b   Hsu, Hey Chi ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

Cyclin D1; Cyclin E; G1 cyclins; Hepatocellular carcinoma; p53 Mutation; Prognosis

Indexed keywords

CYCLIN D1; CYCLIN E; MESSENGER RNA; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032147077     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80014-7     Document Type: Article

References (58)

1. 1 cyclins. Cell. 73:1993;1059-1065.
2. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
3. 1 phase progression: cycling on cue. Cell. 79:1994;551-555.
4. 1 events and regulation of cell proliferation. Science. 246:1989;603-608.
5. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus DNA integration in a cyclin A gene in a hepatocellular carcinoma. Nature (Lond). 343:1990;555-557.
6. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:1991;512-515.
7. Leach FS, Elledge SJ, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 53:1993;1986-1989.
8. Jiang W, Kahn SM, Tomita N, Zhang Y-J, Lu S-H, Weinstein IB. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52:1992;2980-2983.
9. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA. 90:1993;1112-1116.
10. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 6:1991;439-444.
11. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 7:1992;355-361.
12. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cylin E, a potential prognostic marker for breast cancer. Cancer Res. 54:1994;380-385.
13. 1. Genes Dev. 7:1993;812-821.
14. 1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
15. 1-S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol. 14:1994;1669-1679.
16. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond). 365:1993;349-352.
17. 1 in mammalian fibroblasts. Science. 259:1993;1908-1912.
18. 1 progression. Oncogene. 9:1994;2663-2674.
19. Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev. 7:1993;331-342.
20. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, et al. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA. 90:1993;3685-3689.
21. Spitkovsky D, Steiner P, Lukas J, Lees E, Pagano M, Schulze A, et al. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. J Virol. 68:1994;2206-2214.
22. 1. J Cell Biol. 125:1994;625-638.
23. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
24. Muller H, Lucas J, Schneider A, Warthoe P, Bartek J, Eilers M, et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA. 91:1994;2945-2949.
25. Pagano M, Theodoras AM, Tam SW, Draetta G. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1994;1627-1639.
26. 1-S protein kinase. Science. 257-41:1992.
27. Lees E, Faha B, Dulic V, Reed SI, Harlow E, Cyclin E/cdk2, a temporally distinct manner. . and cyclin A/cdk2 kinases associated with p107 and E2F in Genes Dev. 6:192;1874-1885.
28. 1 in mammalian fibroblasts. Science. 259:1993;1908-1911.
29. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
30. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinase. Nature (Lond). 366:1993;701-704.
31. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The 21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
32. Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI, et al. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas: a study of 150 cases. Cancer (Phila). 73:1994;42-47.
33. Hsu HC, Peng SY, Lai PL, Chu JS, Lee PH. Mutations of p53 gene in hepatocellular carcinoma (HCC) correlate with tumor progression and patient prognosis. Int J Oncol. 4:1994;1341-1347.
34. Hsu HC, Huang AM, Lai PL, Chien WM, Peng SY, Lin SW. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology. 19:1994;122-128.
35. Hsu HC, Tseng HJ, Lai PL, Lee PH, Chen DS, Peng Sy. Expression of p53 gene in 184 unifocal hepatocellular carcinomas (HCC): association with tumor growth and invasiveness. Cancer Res. 53:1993;4691-4694.
36. Hsu HC, Sheu JC, Lin YH, Chen DS, Lee CS, Hwang LY, et al. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan: a comparison with resected large HCC. Cancer. 56:1985;672-680.
37. Hsu HC, Wu TT, Wu MZ, Sheu JC, Lee CS, Chen DS. Tumor invasiveness and prognosis in resected hepatocellular carcinoma: clinical and pathogenetic implications. Cancer. 61:1988;2095-2099.
38. Peng SY, Lai PL, Chu JS, Lee PH, Tsung PT, Chen DS, et al. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma. Hepatology. 17:1993;35-41.
39. Don RH, Cox PT, Wainwright BJ, Baker K, Mattich JS. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:1991;4008.
40. Chelly J, Kaplan J-C, Maire P, Cautron S, Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature. 333:1988;858-860.
41. Rupp RAW, Weintraub H. Ubiquitous MyoD transcription at the midblastula transition proceeds induction-dependent MyoD expression in presumptive mesoderm of X. laevis. Cell. 65:1991;927-937.
42. Finke J, Fritzen R, Ternes P, Lange W, Dolken G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissue by PCR. BioTechniques. 14:1993;448-453.
43. Hsu HC, Chiou TJ, Chen ZY, Lee CS, Lee PH, Peng SY. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 3:1991;923-928.
44. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54:1994;3107-3110.
45. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun. 196:1993;1010-1016.
46. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene. 10:1995;775-778.
47. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;975-978.
48. Albrecht JH, Hu MY, Cerra FB. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun. 209:1995;648-655.
49. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene. 9:1994;707-718.
50. Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doli Y, et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene. 10:1995;953-961.
51. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res. 217:1995;205-216.
52. Spitkovsky D, Steiner P, Gopalkrishnan RV, Eilers M, Jansen-Durr P. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes. Oncogene. 10:1995;2421-2425.
53. Gaeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;8-91.
54. Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch. 429:1996;13-19.
55. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, et al. P53 function as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 10:1990;5772-5781.
56. 1 phase. Proc Natl Acad Sci USA. 89:1992;9210-9214.
57. Martinez J, Georgoff L, Martinez J, Levine AJ. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:1991;151-159.
58. Mercer WE, Shields MT, Amin M, Sauver GJ, Appella E, Romano JW, et al. Negative growth regulation in glioblastoma tumor cell line that conditionally expresses human wildtype p53. Proc Natl Acad Sci USA. 87:1990;6166-6170.